Production (Stage)
The Chemours Company
CC
$10.30
-$0.55-5.07%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.37B | 1.39B | 1.50B | 1.54B | 1.36B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37B | 1.39B | 1.50B | 1.54B | 1.36B |
| Cost of Revenue | 1.13B | 1.12B | 1.22B | 1.23B | 1.08B |
| Gross Profit | 236.00M | 273.00M | 286.00M | 306.00M | 284.00M |
| SG&A Expenses | 121.00M | 199.00M | 109.00M | 152.00M | 136.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.28B | 1.35B | 1.35B | 1.41B | 1.24B |
| Operating Income | 88.00M | 48.00M | 148.00M | 128.00M | 120.00M |
| Income Before Tax | 0.00 | 9.00M | -30.00M | 82.00M | 70.00M |
| Income Tax Expenses | 4.00M | 17.00M | -3.00M | 12.00M | 16.00M |
| Earnings from Continuing Operations | -4.00M | -8.00M | -27.00M | 70.00M | 54.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.00M | -8.00M | -27.00M | 70.00M | 54.00M |
| EBIT | 88.00M | 48.00M | 148.00M | 128.00M | 120.00M |
| EBITDA | 165.00M | 126.00M | 226.00M | 202.00M | 191.00M |
| EPS Basic | -0.03 | -0.05 | -0.18 | 0.47 | 0.36 |
| Normalized Basic EPS | 0.13 | -0.03 | 0.40 | 0.29 | 0.30 |
| EPS Diluted | -0.03 | -0.06 | -0.18 | 0.46 | 0.36 |
| Normalized Diluted EPS | 0.13 | -0.03 | 0.40 | 0.29 | 0.30 |
| Average Basic Shares Outstanding | 149.92M | 149.83M | 149.70M | 149.41M | 149.04M |
| Average Diluted Shares Outstanding | 149.92M | 149.83M | 149.70M | 150.12M | 150.05M |
| Dividend Per Share | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Payout Ratio | -925.00% | -450.00% | -140.74% | 52.86% | 68.52% |